LOS ANGELES--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of Xerostomia, dermatological conditions, and acute respiratory diseases, announced today that it has acquired the exclusive license to market a new over-the- counter intranasal lubricant developed by Dr. Donald Carter, MD, PC, a Colorado based Otolaryngologist. Licensing this nasal gel is part of Auriga’s strategic plan to grow its Consumer Brands Division. The company introduced Zinx Lozenges into the OTC cough/cold category in February and will introduce additional Zinx OTC products this summer. Auriga also markets a prescription-only line of Zinx products through its 200+ person nationwide sales force.
